drugset / Trial / NCT01089790
Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background Treatment With Glimepiride Alone or in Combination With Metformin or With Pioglitazone Alone
Non-randomizedParallel-groupTriple-blindTreatment
Summary
This study will evaluate the long-term safety and efficacy of dutogliptin in patients with type 2 diabetes mellitus (T2DM).
Timeline
- Start
- 2010-03
- Primary completion
- 2010-08
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dutogliptin | Small molecule | 400 mg | — |
| Comparator | Sitagliptin | Small molecule | 100 mg | — |